Atlas company financials

GILEAD SCIENCES, INC.

Standardized 19-year financial series for GILEAD SCIENCES, INC., built from filing-derived source data and exposed in JSON, CSV, and XLSX so it can feed iterFact artifacts or analyst workflows without hand-entering the numbers.

United StatesCIK 0000882095FY2007 → FY2025

Open JSON Download CSV Download XLSX Quarterly JSON Summary JSON Filing index

Latest fiscal year

FY2025

Revenue

$29.4B

Adjusted EBITDA

—

Net result

$8.5B

Net financial debt

—

Latest source: FY2025 filing · published data snapshot generated April 26, 2026

Phase 2 summary

Latest quarter, TTM, and growth are now pre-computed for chat and templates.

Latest quarter revenue

$7.8B

TTM revenue

$29.1B

TTM free cash flow

—

Latest quarter net result

$3.1B

Quarterly coverage: 53 periods · latest quarter FY2025-Q3 · TTM revenue growth 6.5%.

What this gives you

A proof-of-concept company data surface, not a dead PDF shelf.

The same standardized payload behind this page is exposed through downloadable CSV and XLSX files plus a stable JSON route. That makes it usable as a live input to iterFact templates, a spreadsheet handoff, or a future API surface without re-normalizing the source documents again.

Source audit

Official links first, raw iterFact payloads right next to them.

Official sources

SEC EDGAR companyfacts
comparative · gilead-sciences-inc-fy2007 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2010-03-01 · Retrieved: 2026-04-26T11:38:43.145001+00:00
SEC EDGAR companyfacts
primary · gilead-sciences-inc-fy2010 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2011-02-28 · Retrieved: 2026-04-26T11:38:43.145001+00:00
SEC EDGAR companyfacts
primary · gilead-sciences-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2012-02-23 · Retrieved: 2026-04-26T11:38:43.145001+00:00
SEC EDGAR companyfacts
us-gaap:ResearchAndDevelopmentExpense · us gaap companyfacts · comparative · gilead-sciences-inc-fy2011 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2014-02-25 · Retrieved: 2026-04-26T11:38:43.145001+00:00
SEC EDGAR companyfacts
primary · gilead-sciences-inc-fy2012 · Attribution: U.S. Securities and Exchange Commission EDGAR filings and companyfacts data. · Release: 2013-02-27 · Retrieved: 2026-04-26T11:38:43.145001+00:00

Ten-year series

Headline company financials by fiscal year

Fiscal year	Revenue	Adj. EBITDA	EBIT	Net result	Op. cash flow	Capex	Net debt	Status
FY2007	4B	—	2B	2B	2B	—	—	comparative annual fact carried from later 10k · missing accounts receivable · missing adjusted ebitda · missing capex · missing current assets · missing current liabilities · missing free cash flow · missing gross profit · missing inventory · missing net financial debt · missing research and development · missing total assets
FY2008	5B	—	3B	2B	2B	—	—	comparative annual fact carried from later 10k · missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit · missing net financial debt · missing research and development
FY2009	7B	—	4B	3B	3B	—	—	missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit · missing net financial debt · missing research and development
FY2010	8B	—	4B	3B	3B	—	—	missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit · missing net financial debt · missing research and development
FY2011	8B	—	4B	3B	4B	—	-2B	missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit
FY2012	9B	—	4B	3B	3B	—	4B	missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit
FY2013	11B	—	5B	3B	3B	-134M	5B	missing adjusted ebitda · missing gross profit
FY2014	25B	—	15B	12B	13B	—	2B	missing adjusted ebitda · missing capex · missing free cash flow · missing gross profit

Filing provenance